V

Vaxart
D

VXRT

0.81290
USD
0.05
(5.96%)
مغلق
حجم التداول
11,530
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
184,918,338
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APDN
    -0.00730
    (-4.03%)
    0.17370 USD
    AZN
    AZN
    0.265
    (0.39%)
    68.205 USD
    BNTX
    BNTX
    -2.010
    (-1.71%)
    115.330 USD
    C
    CODX
    0.04950
    (6.20%)
    0.84780 USD
    I
    INO
    0.06500
    (2.96%)
    2.26000 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    N
    NVAX
    0.02500
    (0.28%)
    8.84500 USD
    PFE
    PFE
    -0.621
    (-2.33%)
    26.015 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    V
    VIR
    0.090
    (0.86%)
    10.520 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Vaxart

القطاع: Healthcare
الصناعة: Biotechnology
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.